United States · Markets & Finance · CNBC

Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals

Published by CNBC · United States 1 h ago

Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.

Read the full article on CNBC Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbc.com)

Also worth reading

Google won a court dismissal of publishers' antitrust suits over AI search summaries

The Latest Challenge to Data Centers? Restive Investors.

BNB Chain crosses $1B in tokenized stocks, ETFs as market hits $3.7B

Cboe wants to turn VIX into a never-ending trade

US Designates Russia's A7 Network as Transnational Criminal Organization

Business Insider

Where every US governor stands on AI and the data-center boom